Drug Shortage Report for DILTIAZEM CD
| Report ID | 134041 |
| Drug Identification Number | 02446022 |
| Brand name | DILTIAZEM CD |
| Common or Proper name | DILTIAZEM CD |
| Company Name | SIVEM PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
| Strength(s) | 300MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C08DB |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2021-01-11 |
| Estimated end date | Unknown |
| Actual end date | 2024-05-31 |
| Shortage status | Resolved |
| Updated date | 2024-07-04 |
| Company comments | Supplier switch |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-07-04 | French | Compare |
| v3 | 2024-07-04 | English | Compare |
| v2 | 2021-02-12 | French | Compare |
| v1 | 2021-02-12 | English | Compare |
Showing 1 to 4 of 4